Therapeutic effect of Terminalia Chebula extract on Parkinson's disease
Phase 2
- Conditions
- Parkinson's disease.Parkinson's disease
- Registration Number
- IRCT20201029049187N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients over 30 years of age
with Parkinson'sAge under 70 years
Patients who have been definitively diagnosed by a Parkinson's neurologist
Patients who have had symptoms for less than 3 months
Exclusion Criteria
Age over 70 years
Age under 30 years
Uncertain diagnosis of Parkinson's
Has had Parkinson's symptoms for more than 3 months and has not been diagnosed
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Parkinson's catatonia. Timepoint: Before the intervention and week 2, 4, 6 after intervention. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Quality of life Score and Symptoms. Timepoint: Before the start of the study and 2 months after the start of the study. Method of measurement: Parkinson's Disease Questionnaire =PDQ-39.